Cull G - Search Results

1

Therapeutic drug monitoring for busulfan in plasma during conditioning chemotherapy for autologous stem cell transplantation in relapsed primary cerebral lymphoma.

Cull G, O'Halloran S, Ilett KF. Cull G, et al. Ther Drug Monit. 2010 Jun;32(3):333-7. doi: 10.1097/FTD.0b013e3181da0795. Ther Drug Monit. 2010. PMID: 20386358

2

Effective clearance of Ara-U the major metabolite of cytosine arabinoside (Ara-C) by hemodialysis in a patient with lymphoma and end-stage renal failure.

Radeski D, Cull GM, Cain M, Hackett LP, Ilett KF. Radeski D, et al. Cancer Chemother Pharmacol. 2011 Apr;67(4):765-8. doi: 10.1007/s00280-010-1373-2. Epub 2010 Jun 8. Cancer Chemother Pharmacol. 2011. PMID: 20532508

3

High-dose therapy and autologous stem cell transplantation may only be applicable to selected patients with secondary CNS diffuse large B-cell lymphoma.

Cheah CY, Joske D, Cull G, Gilbertson M, Opat SS, Tam CS, Wirth A, Seymour JF. Cheah CY, et al. Among authors: cull g. Br J Haematol. 2017 Sep;178(6):991-994. doi: 10.1111/bjh.14187. Epub 2016 Jul 29. Br J Haematol. 2017. PMID: 27470657 Free article. No abstract available.

4

Preliminary experience of allogeneic stem cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH conditioning: an effective regimen with low procedure-related toxicity.

Cull GM, Haynes AP, Byrne JL, Carter GI, Miflin G, Rebello P, Hale G, Waldmann H, Russell NH. Cull GM, et al. Br J Haematol. 2000 Mar;108(4):754-60. doi: 10.1046/j.1365-2141.2000.01879.x. Br J Haematol. 2000. PMID: 10792280 Free article.

5

Allogeneic stem-cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH (+/- fludarabine) conditioning combined with post-transplant donor-lymphocyte infusion.

Lush RJ, Haynes AP, Byrne J, Cull GM, Carter GI, Pagliuca A, Parker JE, Mufti G, Mahendra P, Craddock CF, Lui Yin JA, Garg M, Prentice HG, Potter MN, Russell NH. Lush RJ, et al. Among authors: cull gm. Cytotherapy. 2001;3(3):203-10. doi: 10.1080/146532401753174034. Cytotherapy. 2001. PMID: 12171727 Clinical Trial.

6

Induction with oral chemotherapy (CID) followed by early autologous stem cell transplantation for de novo multiple myeloma patients.

Spencer A, Seldon M, Deveridge S, Cobcroft R, Cull G, Marlton P, Enno A, Gill D. Spencer A, et al. Among authors: cull g. Hematol J. 2004;5(3):216-21. doi: 10.1038/sj.thj.6200342. Hematol J. 2004. PMID: 15167907 Clinical Trial.

7

Lymphocyte reconstitution following autologous stem cell transplantation for progressive MS.

Cull G, Hall D, Fabis-Pedrini MJ, Carroll WM, Forster L, Robins F, Ghassemifar R, Crosbie C, Walters S, James I, Augustson B, Kermode AK. Cull G, et al. Mult Scler J Exp Transl Clin. 2017 Mar 23;3(1):2055217317700167. doi: 10.1177/2055217317700167. eCollection 2017 Jan-Mar. Mult Scler J Exp Transl Clin. 2017. PMID: 28607754 Free PMC article.

8

van der Meulen M, Bakunina K, Nijland M, Minnema MC, Cull G, Stevens WBC, Baars JW, Mason KD, Beeker A, Beijert M, Taphoorn MJB, van den Bent MJ, Issa S, Doorduijn JK, Bromberg JEC, Dirven L. van der Meulen M, et al. Among authors: cull g. Ann Oncol. 2020 Aug;31(8):1046-1055. doi: 10.1016/j.annonc.2020.04.014. Epub 2020 May 3. Ann Oncol. 2020. PMID: 32371123 Free article. Clinical Trial.

9

Salvage chemotherapy for relapsed and resistant lymphoma with a carboplatin containing schedule--EPIC.

Richardson DS, Tighe M, Cull G, Johnson SA, Phillips MJ. Richardson DS, et al. Among authors: cull g. Hematol Oncol. 1994 May-Jun;12(3):125-8. doi: 10.1002/hon.2900120304. Hematol Oncol. 1994. PMID: 7959640

10

Low incidence of human herpesvirus 8 in stem cell collections from myeloma patients.

Cull GM, Carter GI, Timms JM, Thomson BJ, Russell NH, Haynes AP. Cull GM, et al. Bone Marrow Transplant. 1999 Apr;23(8):759-61. doi: 10.1038/sj.bmt.1701674. Bone Marrow Transplant. 1999. PMID: 10231136

11

Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14.

Hertzberg M, Gandhi MK, Trotman J, Butcher B, Taper J, Johnston A, Gill D, Ho SJ, Cull G, Fay K, Chong G, Grigg A, Lewis ID, Milliken S, Renwick W, Hahn U, Filshie R, Kannourakis G, Watson AM, Warburton P, Wirth A, Seymour JF, Hofman MS, Hicks RJ; Australasian Leukaemia Lymphoma Group (ALLG). Hertzberg M, et al. Among authors: cull g. Haematologica. 2017 Feb;102(2):356-363. doi: 10.3324/haematol.2016.154039. Epub 2016 Nov 10. Haematologica. 2017. PMID: 28143954 Free PMC article. Clinical Trial.

12

Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study.

Bromberg JEC, Issa S, Bakunina K, Minnema MC, Seute T, Durian M, Cull G, Schouten HC, Stevens WBC, Zijlstra JM, Baars JW, Nijland M, Mason KD, Beeker A, van den Bent MJ, Beijert M, Gonzales M, de Jong D, Doorduijn JK. Bromberg JEC, et al. Among authors: cull g. Lancet Oncol. 2019 Feb;20(2):216-228. doi: 10.1016/S1470-2045(18)30747-2. Epub 2019 Jan 7. Lancet Oncol. 2019. PMID: 30630772 Clinical Trial.

13

Prognostic factors and the impact of frontline therapy in peripheral T-cell lymphoma: 10 years of 'real-world' experience from Western Australia.

Kuzich JA, Hutchison AP, Lim KJC, Smallbone P, Denning K, Wright MP, Cull G, Leahy MF, Joske DJL, Radeski D, Purtill D. Kuzich JA, et al. Among authors: cull g. Leuk Lymphoma. 2019 Dec;60(14):3417-3425. doi: 10.1080/10428194.2019.1637865. Epub 2019 Jul 15. Leuk Lymphoma. 2019. PMID: 31304820

14

Marginal zone lymphoma causing accelerated progression of chronic kidney disease.

Samarasinghe A, Wong D, Cull G, Chakera A. Samarasinghe A, et al. Among authors: cull g. BMJ Case Rep. 2019 Nov 10;12(11):e230270. doi: 10.1136/bcr-2019-230270. BMJ Case Rep. 2019. PMID: 31712228 Free PMC article.

15

Neurocognitive functioning and radiologic changes in primary CNS lymphoma patients: results from the HOVON 105/ALLG NHL 24 randomized controlled trial.

van der Meulen M, Dirven L, Habets EJJ, Bakunina K, Smits M, Achterberg HC, Seute T, Cull G, Schouten H, Zijlstra JM, Brandsma D, Enting RH, Beijert M, Taphoorn MJB, van den Bent MJ, Issa S, Doorduijn JK, Bromberg JEC. van der Meulen M, et al. Among authors: cull g. Neuro Oncol. 2021 Aug 2;23(8):1315-1326. doi: 10.1093/neuonc/noab021. Neuro Oncol. 2021. PMID: 33560442 Free PMC article. Clinical Trial.

16

Zanubrutinib for the treatment of relapsed or refractory mantle cell lymphoma.

Tam CS, Opat S, Simpson D, Cull G, Munoz J, Phillips TJ, Kim WS, Rule S, Atwal SK, Wei R, Novotny W, Huang J, Wang M, Trotman J. Tam CS, et al. Among authors: cull g. Blood Adv. 2021 Jun 22;5(12):2577-2585. doi: 10.1182/bloodadvances.2020004074. Blood Adv. 2021. PMID: 34152395 Free PMC article. Clinical Trial.

17

How comparable are patient outcomes in the "real-world" with populations studied in pivotal AML trials?

Tiong IS, Wall M, Bajel A, Kalro A, Fleming S, Roberts AW, Thiagarajah N, Chua CC, Latimer M, Yeung D, Marlton P, Johnston A, Enjeti A, Fong CY, Cull G, Larsen S, Kennedy G, Schwarer A, Kipp D, Ramanathan S, Verner E, Tiley C, Morris E, Hahn U, Moore J, Taper J, Purtill D, Warburton P, Stevenson W, Murphy N, Tan P, Beligaswatte A, Mutsando H, Hertzberg M, Shortt J, Szabo F, Dunne K, Wei AH; Australasian Leukaemia and Lymphoma Group (ALLG). Tiong IS, et al. Among authors: cull g. Blood Cancer J. 2024 Mar 26;14(1):54. doi: 10.1038/s41408-024-00996-x. Blood Cancer J. 2024. PMID: 38531863 Free PMC article.

18

Collection and recruitment of CD34+ cells during large-volume leukapheresis.

Cull G, Ivey J, Chase P, Picciuto R, Herrmann R, Cannell P. Cull G, et al. J Hematother. 1997 Aug;6(4):309-14. doi: 10.1089/scd.1.1997.6.309. J Hematother. 1997. PMID: 9377069 Clinical Trial.

19

The effect of the serotherapy regimen used and the marrow cell dose received on rejection, graft-versus-host disease and outcome following unrelated donor bone marrow transplantation for leukaemia.

Byrne JL, Stainer C, Cull G, Haynes AP, Bessell EM, Hale G, Waldmann H, Russell NH. Byrne JL, et al. Among authors: cull g. Bone Marrow Transplant. 2000 Feb;25(4):411-7. doi: 10.1038/sj.bmt.1702165. Bone Marrow Transplant. 2000. PMID: 10723585

20

Prognostic nomogram for diffuse large B-cell lymphoma incorporating the International Prognostic Index with interim-positron emission tomography findings.

Chow A, Phillips M, Siew T, Cull G, Augustson B, Ward M, Joske D. Chow A, et al. Among authors: cull g. Intern Med J. 2013 Aug;43(8):932-9. doi: 10.1111/imj.12194. Intern Med J. 2013. PMID: 23692386

21

Phase 1 study of the selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLL.

Tam CS, Trotman J, Opat S, Burger JA, Cull G, Gottlieb D, Harrup R, Johnston PB, Marlton P, Munoz J, Seymour JF, Simpson D, Tedeschi A, Elstrom R, Yu Y, Tang Z, Han L, Huang J, Novotny W, Wang L, Roberts AW. Tam CS, et al. Among authors: cull g. Blood. 2019 Sep 12;134(11):851-859. doi: 10.1182/blood.2019001160. Epub 2019 Jul 24. Blood. 2019. PMID: 31340982 Free PMC article. Clinical Trial.

22

An international multicenter retrospective analysis of patients with extranodal marginal zone lymphoma and histologically confirmed central nervous system and dural involvement.

Sunderland AJ, Steiner RE, Al Zahrani M, Pinnix CC, Dabaja BS, Gunther JR, Nastoupil LJ, Jerkeman M, Joske D, Cull G, El-Galaly T, Villa D, Cheah CY. Sunderland AJ, et al. Among authors: cull g. Cancer Med. 2020 Jan;9(2):663-670. doi: 10.1002/cam4.2732. Epub 2019 Dec 5. Cancer Med. 2020. PMID: 31808316 Free PMC article.

23

Chronic lymphocytic leukaemia Australasian consensus practice statement.

Anderson MA, Bennett R, Badoux X, Best G, Chia N, Cochrane T, Cull G, Crassini K, Harrup R, Jackson S, Kuss B, Lasica M, Lew TE, Marlton P, Opat S, Palfreyman E, Polizzotto MN, Ratnasingam S, Seymour JF, Soosapilla A, Talaulikar D, Tam CS, Weinkove R, Wight J, Mulligan SP. Anderson MA, et al. Among authors: cull g. Intern Med J. 2023 Sep;53(9):1678-1691. doi: 10.1111/imj.16207. Intern Med J. 2023. PMID: 37743239 Free article.

24

Synchronous biphenotypic Richter syndrome with Epstein-Barr virus-positive nodal classical Hodgkin lymphoma and bone marrow diffuse large B-cell lymphoma.

Cheah CY, Spagnolo D, Frost F, Cull G. Cheah CY, et al. Among authors: cull g. Histopathology. 2016 Oct;69(4):707-10. doi: 10.1111/his.12984. Epub 2016 May 30. Histopathology. 2016. PMID: 27079556 No abstract available.

25

Improvement in Parameters of Hematologic and Immunologic Function and Patient Well-being in the Phase III RESONATE Study of Ibrutinib Versus Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.

Barrientos JC, O'Brien S, Brown JR, Kay NE, Reddy NM, Coutre S, Tam C, Mulligan S, Jaeger U, Devereux S, Pocock C, Robak T, Schuster SJ, Schuh A, Gill D, Bloor A, Dearden C, Moreno C, Cull G, Hamblin M, Jones JA, Eckert K, Solman IG, Suzuki S, Hsu E, James DF, Byrd JC, Hillmen P. Barrientos JC, et al. Among authors: cull g. Clin Lymphoma Myeloma Leuk. 2018 Dec;18(12):803-813.e7. doi: 10.1016/j.clml.2018.08.007. Epub 2018 Aug 18. Clin Lymphoma Myeloma Leuk. 2018. PMID: 30249389 Free PMC article. Clinical Trial.

26

Zanubrutinib for treatment-naïve and relapsed/refractory chronic lymphocytic leukaemia: long-term follow-up of the phase I/II AU-003 study.

Cull G, Burger JA, Opat S, Gottlieb D, Verner E, Trotman J, Marlton P, Munoz J, Johnston P, Simpson D, Stern JC, Prathikanti R, Wu K, Novotny W, Huang J, Tam CS. Cull G, et al. Br J Haematol. 2022 Mar;196(5):1209-1218. doi: 10.1111/bjh.17994. Epub 2021 Dec 16. Br J Haematol. 2022. PMID: 34915592 Free PMC article. Clinical Trial.

27

Incidence of c-Cbl mutations in human acute myeloid leukaemias in an Australian patient cohort.

Ghassemifar R, Thien CB, Finlayson J, Joske D, Cull GM, Augustson B, Langdon WY. Ghassemifar R, et al. Pathology. 2011 Apr;43(3):261-5. doi: 10.1097/PAT.0b013e328343ca4b. Pathology. 2011. PMID: 21436637

28

Differential expression of the Bcl-2 and Bax isoforms in CD19 positive B-lymphocytes isolated from patients diagnosed with chronic lymphocytic leukaemia.

Ghassemifar R, Forster L, Finlayson J, Calogero T, Augustson B, Joske D, Cull G. Ghassemifar R, et al. Among authors: cull g. Pathology. 2012 Dec;44(7):632-7. doi: 10.1097/PAT.0b013e32835a0142. Pathology. 2012. PMID: 23172082

29

Anaplastic large-cell lymphoma associated with breast implants: a unique entity within the spectrum of peri-implant effusions.

Chai SM, Kavangh S, Ooi SS, Sterrett GF, Cull G, Plunkett M, Spagnolo D, Amanuel B, Joske D, Leslie C, Barham T, Frost F. Chai SM, et al. Among authors: cull g. Diagn Cytopathol. 2014 Nov;42(11):929-38. doi: 10.1002/dc.23152. Epub 2014 Mar 31. Diagn Cytopathol. 2014. PMID: 24687769

30

Green tea polyphenol "epigallocatechin-3-gallate", differentially induces apoptosis in CLL B-and T-Cells but not in healthy B-and T-Cells in a dose dependant manner.

Cornwall S, Cull G, Joske D, Ghassemifar R. Cornwall S, et al. Among authors: cull g. Leuk Res. 2016 Dec;51:56-61. doi: 10.1016/j.leukres.2016.10.011. Epub 2016 Nov 2. Leuk Res. 2016. PMID: 27855324

31

Frequency of bowel perforation and impact of bowel rest in aggressive non-Hodgkin lymphoma with gastrointestinal involvement.

Chin CK, Tsang E, Mediwake H, Khair W, Biccler J, Hapgood G, Mollee P, Nizich Z, Joske D, Radeski D, Cull G, Villa D, El-Galaly TC, Cheah CY. Chin CK, et al. Among authors: cull g. Br J Haematol. 2019 Mar;184(5):826-828. doi: 10.1111/bjh.15173. Epub 2018 Apr 20. Br J Haematol. 2019. PMID: 29676487 Free article. Clinical Trial. No abstract available.

32

Zanubrutinib for the treatment of patients with Waldenström macroglobulinemia: 3 years of follow-up.

Trotman J, Opat S, Gottlieb D, Simpson D, Marlton P, Cull G, Munoz J, Tedeschi A, Roberts AW, Seymour JF, Atwal SK, Yu Y, Novotny W, Holmgren E, Tan Z, Hilger JD, Huang J, Tam CS. Trotman J, et al. Among authors: cull g. Blood. 2020 Oct 29;136(18):2027-2037. doi: 10.1182/blood.2020006449. Blood. 2020. PMID: 32698195 Free PMC article. Clinical Trial.

33

Zanubrutinib for the treatment of MYD88 wild-type Waldenström macroglobulinemia: a substudy of the phase 3 ASPEN trial.

Dimopoulos M, Sanz RG, Lee HP, Trneny M, Varettoni M, Opat S, D'Sa S, Owen RG, Cull G, Mulligan S, Czyz J, Castillo JJ, Motta M, Siddiqi T, Gironella Mesa M, Granell Gorrochategui M, Talaulikar D, Zinzani PL, Askari E, Grosicki S, Oriol A, Rule S, Kloczko J, Tedeschi A, Buske C, Leblond V, Trotman J, Chan WY, Michel J, Schneider J, Tan Z, Cohen A, Huang J, Tam CS. Dimopoulos M, et al. Among authors: cull g. Blood Adv. 2020 Dec 8;4(23):6009-6018. doi: 10.1182/bloodadvances.2020003010. Blood Adv. 2020. PMID: 33284944 Free PMC article. Clinical Trial.

34

Extent of radiological response does not reflect survival in primary central nervous system lymphoma.

van der Meulen M, Postma AA, Smits M, Bakunina K, Minnema MC, Seute T, Cull G, Enting RH, van der Poel M, Stevens WBC, Brandsma D, Beeker A, Doorduijn JK, Issa S, van den Bent MJ, Bromberg JEC. van der Meulen M, et al. Among authors: cull g. Neurooncol Adv. 2021 Feb 15;3(1):vdab007. doi: 10.1093/noajnl/vdab007. eCollection 2021 Jan-Dec. Neurooncol Adv. 2021. PMID: 33615224 Free PMC article.

35

Systemic mastocytosis associated with two clonal haematological neoplasms.

Chee A, Erber WN, Cull G. Chee A, et al. Among authors: cull g. Pathology. 2022 Apr;54(3):361-363. doi: 10.1016/j.pathol.2021.06.117. Epub 2021 Aug 18. Pathology. 2022. PMID: 34419265 No abstract available.

36

Improving outcomes for patients with lymphoma: design and development of the Australian and New Zealand Lymphoma and Related Diseases Registry.

Lymphoma and Related Diseases Registry Investigators. Lymphoma and Related Diseases Registry Investigators. BMC Med Res Methodol. 2022 Oct 10;22(1):266. doi: 10.1186/s12874-022-01728-0. BMC Med Res Methodol. 2022. PMID: 36217114 Free PMC article.

37

Identification of tumours with the CD43 only phenotype during the investigation of suspected lymphoma: a heterogeneous group not necessarily of T cell origin.

Kennedy GA, Cull G, Gill D, Marlton P, Norris D, Cobcroft R. Kennedy GA, et al. Among authors: cull g. Pathology. 2002 Feb;34(1):46-50. doi: 10.1080/00313020120105633. Pathology. 2002. PMID: 11902445

38

Neutrophil dysplasia characterised by a pseudo-Pelger-Huet anomaly occurring with the use of mycophenolate mofetil and ganciclovir following renal transplantation: a report of five cases.

Kennedy GA, Kay TD, Johnson DW, Hawley CM, Campbell SB, Isbel NM, Marlton P, Cobcroft R, Gill D, Cull G. Kennedy GA, et al. Among authors: cull g. Pathology. 2002 Jun;34(3):263-6. doi: 10.1080/0031302022013136. Pathology. 2002. PMID: 12109788

39

Incidence and nature of CD20-negative relapses following rituximab therapy in aggressive B-cell non-Hodgkin's lymphoma: a retrospective review.

Kennedy GA, Tey SK, Cobcroft R, Marlton P, Cull G, Grimmett K, Thomson D, Gill D. Kennedy GA, et al. Among authors: cull g. Br J Haematol. 2002 Nov;119(2):412-6. doi: 10.1046/j.1365-2141.2002.03843.x. Br J Haematol. 2002. PMID: 12406079 Free article.

40

Prolonged haematological toxicity from the hyper-CVAD regimen: manifestations, frequency, and natural history in a cohort of 125 consecutive patients.

Gill S, Lane SW, Crawford J, Cull G, Joske D, Marlton P, Mollee PN, Prince HM, Seymour JF. Gill S, et al. Among authors: cull g. Ann Hematol. 2008 Sep;87(9):727-34. doi: 10.1007/s00277-008-0488-6. Epub 2008 Apr 10. Ann Hematol. 2008. PMID: 18401583

41

When the safety net of treatment has been removed: patients' unmet needs at the completion of treatment for haematological malignancies.

Lobb EA, Joske D, Butow P, Kristjanson LJ, Cannell P, Cull G, Augustson B. Lobb EA, et al. Among authors: cull g. Patient Educ Couns. 2009 Oct;77(1):103-8. doi: 10.1016/j.pec.2009.02.005. Epub 2009 Mar 9. Patient Educ Couns. 2009. PMID: 19272749

42

Results of the APML3 trial incorporating all-trans-retinoic acid and idarubicin in both induction and consolidation as initial therapy for patients with acute promyelocytic leukemia.

Iland H, Bradstock K, Seymour J, Hertzberg M, Grigg A, Taylor K, Catalano J, Cannell P, Horvath N, Deveridge S, Browett P, Brighton T, Chong L, Springall F, Ayling J, Catalano A, Supple S, Collins M, Di Iulio J, Reynolds J; Australasian Leukaemia and Lymphoma Group. Iland H, et al. Haematologica. 2012 Feb;97(2):227-34. doi: 10.3324/haematol.2011.047506. Epub 2011 Oct 11. Haematologica. 2012. PMID: 21993673 Free PMC article. Clinical Trial.

43

All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4).

Iland HJ, Bradstock K, Supple SG, Catalano A, Collins M, Hertzberg M, Browett P, Grigg A, Firkin F, Hugman A, Reynolds J, Di Iulio J, Tiley C, Taylor K, Filshie R, Seldon M, Taper J, Szer J, Moore J, Bashford J, Seymour JF; Australasian Leukaemia and Lymphoma Group. Iland HJ, et al. Blood. 2012 Aug 23;120(8):1570-80; quiz 1752. doi: 10.1182/blood-2012-02-410746. Epub 2012 Jun 19. Blood. 2012. PMID: 22715121 Free article. Clinical Trial.

44

A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia.

Awan FT, Hillmen P, Hellmann A, Robak T, Hughes SG, Trone D, Shannon M, Flinn IW, Byrd JC; LUCID trial investigators. Awan FT, et al. Br J Haematol. 2014 Nov;167(4):466-77. doi: 10.1111/bjh.13061. Epub 2014 Aug 8. Br J Haematol. 2014. PMID: 25130401 Free article. Clinical Trial.

45

A randomized trial of prophylactic palifermin on gastrointestinal toxicity after intensive induction therapy for acute myeloid leukaemia.

Bradstock KF, Link E, Collins M, Di Iulio J, Lewis ID, Schwarer A, Enno A, Marlton P, Hahn U, Szer J, Cull G, Seymour JF; Australasian Leukaemia and Lymphoma Group. Bradstock KF, et al. Among authors: cull g. Br J Haematol. 2014 Dec;167(5):618-25. doi: 10.1111/bjh.13086. Epub 2014 Aug 21. Br J Haematol. 2014. PMID: 25142189 Free article. Clinical Trial.

46

A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: the ASPEN study.

Tam CS, Opat S, D'Sa S, Jurczak W, Lee HP, Cull G, Owen RG, Marlton P, Wahlin BE, Sanz RG, McCarthy H, Mulligan S, Tedeschi A, Castillo JJ, Czyz J, Fernández de Larrea C, Belada D, Libby E, Matous JV, Motta M, Siddiqi T, Tani M, Trneny M, Minnema MC, Buske C, Leblond V, Trotman J, Chan WY, Schneider J, Ro S, Cohen A, Huang J, Dimopoulos M. Tam CS, et al. Among authors: cull g. Blood. 2020 Oct 29;136(18):2038-2050. doi: 10.1182/blood.2020006844. Blood. 2020. PMID: 32731259 Free PMC article. Clinical Trial.

47

Molecular complete response in a patient with chronic lymphocytic leukaemia treated with 2-chlorodeoxyadenosine.

Cull G, Richardson DS, Howe DJ, Hopkins JA, Johnson SA, Phillips MJ. Cull G, et al. Acta Oncol. 1995;34(4):536-7. doi: 10.3109/02841869509094022. Acta Oncol. 1995. PMID: 7605666 No abstract available.

48

Establishing the incidence of myelodysplasia syndrome.

Phillips MJ, Cull GM, Ewings M. Phillips MJ, et al. Among authors: cull gm. Br J Haematol. 1994 Dec;88(4):896-7. doi: 10.1111/j.1365-2141.1994.tb05138.x. Br J Haematol. 1994. PMID: 7819118 No abstract available.

49

Tetrasomy of chromosome 8 in a patient with acute myeloid leukemia.

Cull GM, Howe DJ, Stack-Dunne M, Phillips MJ, Johnson SA. Cull GM, et al. Leuk Lymphoma. 1995 Oct;19(3-4):355-8. doi: 10.3109/10428199509107910. Leuk Lymphoma. 1995. PMID: 8535231

50

Safety and efficacy of pegfilgrastim compared to granulocyte colony stimulating factor (G-CSF) supporting a dose-intensive, rapidly cycling anti-metabolite containing chemotherapy regimen (Hyper-CVAD) for lymphoid malignancy.

Lane SW, Crawford J, Kenealy M, Cull G, Seymour JF, Prince HM, Marlton P, Gill D, Mollee PN. Lane SW, et al. Among authors: cull g. Leuk Lymphoma. 2006 Sep;47(9):1813-7. doi: 10.1080/10428190600632832. Leuk Lymphoma. 2006. PMID: 17064993

51

Limited clinical relevance of imaging techniques in the follow-up of patients with advanced chronic lymphocytic leukemia: results of a meta-analysis.

Eichhorst BF, Fischer K, Fink AM, Elter T, Wendtner CM, Goede V, Bergmann M, Stilgenbauer S, Hopfinger G, Ritgen M, Bahlo J, Busch R, Hallek M; German CLL Study Group (GCLLSG). Eichhorst BF, et al. Blood. 2011 Feb 10;117(6):1817-21. doi: 10.1182/blood-2010-04-282228. Epub 2010 Dec 7. Blood. 2011. PMID: 21139079 Free article.

52

Idarubicin Dose Escalation During Consolidation Therapy for Adult Acute Myeloid Leukemia.

Bradstock KF, Link E, Di Iulio J, Szer J, Marlton P, Wei AH, Enno A, Schwarer A, Lewis ID, D'Rozario J, Coyle L, Cull G, Campbell P, Leahy MF, Hahn U, Cannell P, Tiley C, Lowenthal RM, Moore J, Cartwright K, Cunningham I, Taper J, Grigg A, Roberts AW, Benson W, Hertzberg M, Deveridge S, Rowlings P, Mills AK, Gill D, Bardy P, Campbell L, Seymour JF; Australasian Leukaemia & Lymphoma Group. Bradstock KF, et al. Among authors: cull g. J Clin Oncol. 2017 May 20;35(15):1678-1685. doi: 10.1200/JCO.2016.70.6374. Epub 2017 Apr 3. J Clin Oncol. 2017. PMID: 28368672 Clinical Trial.

53

Pooled safety analysis of zanubrutinib monotherapy in patients with B-cell malignancies.

Tam CS, Dimopoulos M, Garcia-Sanz R, Trotman J, Opat S, Roberts AW, Owen R, Song Y, Xu W, Zhu J, Li J, Qiu L, D'Sa S, Jurczak W, Cull G, Marlton P, Gottlieb D, Munoz J, Phillips T, Du C, Ji M, Zhou L, Guo H, Zhu H, Chan WY, Cohen A, Novotny W, Huang J, Tedeschi A. Tam CS, et al. Among authors: cull g. Blood Adv. 2022 Feb 22;6(4):1296-1308. doi: 10.1182/bloodadvances.2021005621. Blood Adv. 2022. PMID: 34724705 Free PMC article.

54

Recruitment of CD34+ cells during large-volume leukapheresis.

Cull G, Cannell P. Cull G, et al. Transfusion. 1997 Jun;37(6):672-3. doi: 10.1046/j.1537-2995.1997.37697335169.x. Transfusion. 1997. PMID: 9191835 No abstract available.

55

Exacerbation of coagulopathy with concurrent bone marrow necrosis, hepatic and renal dysfunction secondary to all-trans retinoic acid therapy for acute promyelocytic leukemia.

Cull GM, Eikelboom JW, Cannell PK. Cull GM, et al. Hematol Oncol. 1997 Feb;15(1):13-7. doi: 10.1002/(sici)1099-1069(199702)15:1<13::aid-hon593>3.0.co;2-s. Hematol Oncol. 1997. PMID: 9378467

56

Dendritic cells cultured from mononuclear cells and CD34 cells in myeloma do not harbour human herpesvirus 8.

Cull GM, Timms JM, Haynes AP, Russell NH, Irving WL, Ball JK, Thomson BJ. Cull GM, et al. Br J Haematol. 1998 Mar;100(4):793-6. doi: 10.1046/j.1365-2141.1998.00671.x. Br J Haematol. 1998. PMID: 9531351 Free article.

57

Generation of anti-idiotype immune responses following vaccination with idiotype-protein pulsed dendritic cells in myeloma.

Cull G, Durrant L, Stainer C, Haynes A, Russell N. Cull G, et al. Br J Haematol. 1999 Dec;107(3):648-55. doi: 10.1046/j.1365-2141.1999.01735.x. Br J Haematol. 1999. PMID: 10583271 Free article.

58

Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia.

Byrd JC, Brown JR, O'Brien S, Barrientos JC, Kay NE, Reddy NM, Coutre S, Tam CS, Mulligan SP, Jaeger U, Devereux S, Barr PM, Furman RR, Kipps TJ, Cymbalista F, Pocock C, Thornton P, Caligaris-Cappio F, Robak T, Delgado J, Schuster SJ, Montillo M, Schuh A, de Vos S, Gill D, Bloor A, Dearden C, Moreno C, Jones JJ, Chu AD, Fardis M, McGreivy J, Clow F, James DF, Hillmen P; RESONATE Investigators. Byrd JC, et al. N Engl J Med. 2014 Jul 17;371(3):213-23. doi: 10.1056/NEJMoa1400376. Epub 2014 May 31. N Engl J Med. 2014. PMID: 24881631 Free PMC article. Clinical Trial.

59

Symptomatic hypocalcaemia and renal impairment associated with bisphosphonate treatment in patients with multiple myeloma.

Henley D, Kaye J, Walsh J, Cull G. Henley D, et al. Among authors: cull g. Intern Med J. 2005 Dec;35(12):726-8. doi: 10.1111/j.1445-5994.2005.00949.x. Intern Med J. 2005. PMID: 16313549

60

Thrombotic microangiopathy from Australian brown snake (Pseudonaja) envenoming.

Isbister GK, Little M, Cull G, McCoubrie D, Lawton P, Szabo F, Kennedy J, Trethewy C, Luxton G, Brown SG, Currie BJ. Isbister GK, et al. Among authors: cull g. Intern Med J. 2007 Aug;37(8):523-8. doi: 10.1111/j.1445-5994.2007.01407.x. Intern Med J. 2007. PMID: 17640187

61

Dasatinib therapy for systemic mastocytosis: four cases.

Purtill D, Cooney J, Sinniah R, Carnley B, Cull G, Augustson B, Cannell P. Purtill D, et al. Among authors: cull g. Eur J Haematol. 2008 May;80(5):456-8. doi: 10.1111/j.1600-0609.2008.01048.x. Epub 2008 Feb 13. Eur J Haematol. 2008. PMID: 18284618 No abstract available.

62

Hydroa Vacciniforme-Like Lymphoproliferative Disorder in an Adult Patient With Chronic Lymphocytic Leukemia.

Chee A, Wood B, Sadler G, Cull G. Chee A, et al. Among authors: cull g. J Med Cases. 2020 Nov;11(11):366-369. doi: 10.14740/jmc3576. Epub 2020 Sep 23. J Med Cases. 2020. PMID: 34434348 Free PMC article.

63

Time for a new acute myeloid leukaemia classification?

Eikelboom J, Cull G, Erber W. Eikelboom J, et al. Among authors: cull g. Br J Haematol. 1996 Jan;92(1):247-8. Br J Haematol. 1996. PMID: 8562405 No abstract available.

64

Indolent relapse after initial aggressive B-cell lymphoma: a single institution experience in the rituximab era.

Fasser D, Lewis K, Leslie C, Cull G, Radeski D, Augustson B, Howman R, Joske D, Crawford J, Grove C, Cheah CY. Fasser D, et al. Among authors: cull g. Leuk Lymphoma. 2024 Oct 18:1-4. doi: 10.1080/10428194.2024.2416563. Online ahead of print. Leuk Lymphoma. 2024. PMID: 39421976 No abstract available.

65

Vascular resistance indices are higher in the superior than inferior optic nerve head and retina.

Gardiner SK, Cull G, Fortune B. Gardiner SK, et al. Among authors: cull g. Exp Eye Res. 2024 Nov;248:110070. doi: 10.1016/j.exer.2024.110070. Epub 2024 Sep 5. Exp Eye Res. 2024. PMID: 39243927

66

Differences in Systemic Pulse Waveform Between Individuals With Glaucoma, Glaucoma Suspects, and Healthy Controls.

Yang H, Cull G, Yang M, Wang L, Fortune B, Gardiner SK. Yang H, et al. Among authors: cull g. Invest Ophthalmol Vis Sci. 2024 Jul 1;65(8):20. doi: 10.1167/iovs.65.8.20. Invest Ophthalmol Vis Sci. 2024. PMID: 38990070 Free PMC article.

67

Australians with chronic lymphocytic leukaemia continue to have high rates of second primary malignancies in the modern era.

Baggio D, Chung E, Wellard C, Waters N, Cushion T, Chong G, Cochrane T, Cull G, Giri P, Hamad N, Johnston A, Lee D, Murali A, Morgan S, Mulligan S, Talaulikar D, Ratnasingam S, Wood E, Hawkes E, Opat S. Baggio D, et al. Among authors: cull g. Intern Med J. 2024 Jul;54(7):1223-1227. doi: 10.1111/imj.16445. Epub 2024 Jul 7. Intern Med J. 2024. PMID: 38973146

68

Assessment of Time Lag Between Blood Flow, Retinal Nerve Fiber Layer Thickness and Visual Field Sensitivity Changes in Glaucoma.

Higgins BE, Cull G, Gardiner SK. Higgins BE, et al. Among authors: cull g. Invest Ophthalmol Vis Sci. 2024 Apr 1;65(4):7. doi: 10.1167/iovs.65.4.7. Invest Ophthalmol Vis Sci. 2024. PMID: 38564193 Free PMC article.

69

Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemia.

Tam CS, Opat S, D'Sa S, Jurczak W, Lee HP, Cull G, Owen RG, Marlton P, Wahlin BE, García-Sanz R, McCarthy H, Mulligan S, Tedeschi A, Castillo JJ, Czyż J, Fernández De Larrea C, Belada D, Libby E, Matous J, Motta M, Siddiqi T, Tani M, Trněný M, Minnema MC, Buske C, Leblond V, Treon SP, Trotman J, Wu B, Yu Y, Shen Z, Chan WY, Schneider J, Allewelt H, Cohen A, Dimopoulos MA. Tam CS, et al. Among authors: cull g. Blood Adv. 2024 Apr 9;8(7):1639-1650. doi: 10.1182/bloodadvances.2023010906. Blood Adv. 2024. PMID: 38315878 Free PMC article.

70

Survival, neurocognitive function, and health-related quality of life outcomes after rituximab-methotrexate, BCNU, teniposide, and prednisolone for primary CNS lymphoma: Final results of the HOVON 105/ALLG NHL 24 study.

Bromberg JEC, Issa S, van der Holt B, van der Meulen M, Dirven L, Minnema MC, Seute T, Durian M, Cull G, van der Poel MWM, Stevens WBC, Zijlstra JM, Brandsma D, Nijland M, Mason KD, Beeker A, Abrahamse-Testroote MCJ, van den Bent MJ, de Jong D, Doorduijn JK. Bromberg JEC, et al. Among authors: cull g. Neuro Oncol. 2024 Apr 5;26(4):724-734. doi: 10.1093/neuonc/noad224. Neuro Oncol. 2024. PMID: 38037691 Free PMC article. Clinical Trial.

71

Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML: a randomized, placebo-controlled study by the ALLG.

Loo S, Roberts AW, Anstee NS, Kennedy GA, He S, Schwarer AP, Enjeti AK, D'Rozario J, Marlton P, Bilmon IA, Taper J, Cull G, Tiley C, Verner E, Hahn U, Hiwase DK, Iland HJ, Murphy N, Ramanathan S, Reynolds J, Ong DM, Tiong IS, Wall M, Murray M, Rawling T, Leadbetter J, Rowley L, Latimer M, Yuen S, Ting SB, Fong CY, Morris K, Bajel A, Seymour JF, Levis MJ, Wei AH. Loo S, et al. Among authors: cull g. Blood. 2023 Dec 7;142(23):1960-1971. doi: 10.1182/blood.2023020301. Blood. 2023. PMID: 37647654 Free PMC article. Clinical Trial.

72

Utility of Light-Adapted Full-Field Electroretinogram ON and OFF Responses for Detecting Glaucomatous Functional Damage.

Dunn M, Cull G, Reynaud J, Jennings D, Holthausen T, Di Polo A, Fortune B. Dunn M, et al. Among authors: cull g. Transl Vis Sci Technol. 2023 Aug 1;12(8):16. doi: 10.1167/tvst.12.8.16. Transl Vis Sci Technol. 2023. PMID: 37594448 Free PMC article.

73

Zanubrutinib Versus Ibrutinib in Symptomatic Waldenström Macroglobulinemia: Final Analysis From the Randomized Phase III ASPEN Study.

Dimopoulos MA, Opat S, D'Sa S, Jurczak W, Lee HP, Cull G, Owen RG, Marlton P, Wahlin BE, Garcia-Sanz R, McCarthy H, Mulligan S, Tedeschi A, Castillo JJ, Czyz J, Fernández de Larrea C, Belada D, Libby E, Matous J, Motta M, Siddiqi T, Tani M, Trněný M, Minnema MC, Buske C, Leblond V, Treon SP, Trotman J, Chan WY, Schneider J, Allewelt H, Patel S, Cohen A, Tam CS. Dimopoulos MA, et al. Among authors: cull g. J Clin Oncol. 2023 Nov 20;41(33):5099-5106. doi: 10.1200/JCO.22.02830. Epub 2023 Jul 21. J Clin Oncol. 2023. PMID: 37478390 Free PMC article. Clinical Trial.

74

Retinal Vessel Pulsatile Characteristics Associated With Vascular Stiffness Can Predict the Rate of Functional Progression in Glaucoma Suspects.

Gardiner SK, Cull G, Fortune B. Gardiner SK, et al. Among authors: cull g. Invest Ophthalmol Vis Sci. 2023 Jun 1;64(7):30. doi: 10.1167/iovs.64.7.30. Invest Ophthalmol Vis Sci. 2023. PMID: 37335567 Free PMC article.

75

Zanubrutinib, Alone and in Combination With Tislelizumab, for the Treatment of Richter Transformation of Chronic Lymphocytic Leukemia.

Tam C, Munoz J, Cull G, Opat S, Allewelt H, Zhang X, Stern JC, Hilger J, By K, Cohen A, Tedeschi A. Tam C, et al. Among authors: cull g. Hemasphere. 2023 Mar 24;7(4):e870. doi: 10.1097/HS9.0000000000000870. eCollection 2023 Apr. Hemasphere. 2023. PMID: 36999005 Free PMC article. No abstract available.

76

AxoNet 2.0: A Deep Learning-Based Tool for Morphometric Analysis of Retinal Ganglion Cell Axons.

Goyal V, Read AT, Ritch MD, Hannon BG, Rodriguez GS, Brown DM, Feola AJ, Hedberg-Buenz A, Cull GA, Reynaud J, Garvin MK, Anderson MG, Burgoyne CF, Ethier CR. Goyal V, et al. Among authors: cull ga. Transl Vis Sci Technol. 2023 Mar 1;12(3):9. doi: 10.1167/tvst.12.3.9. Transl Vis Sci Technol. 2023. PMID: 36917117 Free PMC article.

77

Downregulation of Retinal Connexin 43 in GFAP-Expressing Cells Modifies Vasoreactivity Induced by Perfusion Ocular Pressure Changes.

Liu G, Li H, Cull G, Wilsey L, Yang H, Reemmer J, Shen HY, Wang F, Fortune B, Bui BV, Wang L. Liu G, et al. Among authors: cull g. Invest Ophthalmol Vis Sci. 2021 Jan 4;62(1):26. doi: 10.1167/iovs.62.1.26. Invest Ophthalmol Vis Sci. 2021. PMID: 33502459 Free PMC article.

78

AxoNet: A deep learning-based tool to count retinal ganglion cell axons.

Ritch MD, Hannon BG, Read AT, Feola AJ, Cull GA, Reynaud J, Morrison JC, Burgoyne CF, Pardue MT, Ethier CR. Ritch MD, et al. Among authors: cull ga. Sci Rep. 2020 May 15;10(1):8034. doi: 10.1038/s41598-020-64898-1. Sci Rep. 2020. PMID: 32415269 Free PMC article.

79

Increased Optic Nerve Head Capillary Blood Flow in Early Primary Open-Angle Glaucoma.

Gardiner SK, Cull G, Fortune B, Wang L. Gardiner SK, et al. Among authors: cull g. Invest Ophthalmol Vis Sci. 2019 Jul 1;60(8):3110-3118. doi: 10.1167/iovs.19-27389. Invest Ophthalmol Vis Sci. 2019. PMID: 31323681 Free PMC article.

80

Hypercapnia Impairs Vasoreactivity to Changes in Blood Pressure and Intraocular Pressure in Rat Retina.

Liu G, Cull G, Wang L, Bui BV. Liu G, et al. Among authors: cull g. Optom Vis Sci. 2019 Jul;96(7):470-476. doi: 10.1097/OPX.0000000000001400. Optom Vis Sci. 2019. PMID: 31274734 Free PMC article.

81

Comparing three different modes of electroretinography in experimental glaucoma: diagnostic performance and correlation to structure.

Wilsey L, Gowrisankaran S, Cull G, Hardin C, Burgoyne CF, Fortune B. Wilsey L, et al. Among authors: cull g. Doc Ophthalmol. 2017 Apr;134(2):111-128. doi: 10.1007/s10633-017-9578-x. Epub 2017 Feb 27. Doc Ophthalmol. 2017. PMID: 28243926 Free PMC article.

82

Glial Cell Contribution to Basal Vessel Diameter and Pressure-Initiated Vascular Responses in Rat Retina.

Li H, Bui BV, Cull G, Wang F, Wang L. Li H, et al. Among authors: cull g. Invest Ophthalmol Vis Sci. 2017 Jan 1;58(1):1-8. doi: 10.1167/iovs.16-20804. Invest Ophthalmol Vis Sci. 2017. PMID: 28055098 Free PMC article.

83

Comparing Optic Nerve Head Rim Width, Rim Area, and Peripapillary Retinal Nerve Fiber Layer Thickness to Axon Count in Experimental Glaucoma.

Fortune B, Hardin C, Reynaud J, Cull G, Yang H, Wang L, Burgoyne CF. Fortune B, et al. Among authors: cull g. Invest Ophthalmol Vis Sci. 2016 Jul 1;57(9):OCT404-12. doi: 10.1167/iovs.15-18667. Invest Ophthalmol Vis Sci. 2016. PMID: 27409499 Free PMC article.

84

Cupping in the Monkey Optic Nerve Transection Model Consists of Prelaminar Tissue Thinning in the Absence of Posterior Laminar Deformation.

Ing E, Ivers KM, Yang H, Gardiner SK, Reynaud J, Cull G, Wang L, Burgoyne CF. Ing E, et al. Among authors: cull g. Invest Ophthalmol Vis Sci. 2016 May 1;57(6):2914–2927. doi: 10.1167/iovs.15-18975. Invest Ophthalmol Vis Sci. 2016. PMID: 27168368 Free PMC article.

85

Macular Structure and Function in Nonhuman Primate Experimental Glaucoma.

Wilsey LJ, Reynaud J, Cull G, Burgoyne CF, Fortune B. Wilsey LJ, et al. Among authors: cull g. Invest Ophthalmol Vis Sci. 2016 Apr;57(4):1892-900. doi: 10.1167/iovs.15-18119. Invest Ophthalmol Vis Sci. 2016. PMID: 27082305 Free PMC article.

86

Total Retinal Blood Flow in a Nonhuman Primate Optic Nerve Transection Model Using Dual-Beam Bidirectional Doppler FD-OCT and Microsphere Method.

Told R, Wang L, Cull G, Thompson SJ, Burgoyne CF, Aschinger GC, Schmetterer L, Werkmeister RM. Told R, et al. Among authors: cull g. Invest Ophthalmol Vis Sci. 2016 Mar;57(3):1432-40. doi: 10.1167/iovs.16-19140. Invest Ophthalmol Vis Sci. 2016. PMID: 27031838

87

Compromised Optic Nerve Blood Flow and Autoregulation Secondary to Neural Degeneration.

Cull G, Told R, Burgoyne CF, Thompson S, Fortune B, Wang L. Cull G, et al. Invest Ophthalmol Vis Sci. 2015 Nov;56(12):7286-92. doi: 10.1167/iovs.15-17879. Invest Ophthalmol Vis Sci. 2015. PMID: 26551332 Free PMC article.

88

Relating Retinal Ganglion Cell Function and Retinal Nerve Fiber Layer (RNFL) Retardance to Progressive Loss of RNFL Thickness and Optic Nerve Axons in Experimental Glaucoma.

Fortune B, Cull G, Reynaud J, Wang L, Burgoyne CF. Fortune B, et al. Among authors: cull g. Invest Ophthalmol Vis Sci. 2015 Jun;56(6):3936-44. doi: 10.1167/iovs.15-16548. Invest Ophthalmol Vis Sci. 2015. PMID: 26087359 Free PMC article.

89

Alterations in molecular pathways in the retina of early experimental glaucoma eyes.

Cao L, Wang L, Cull G, Zhou A. Cao L, et al. Among authors: cull g. Int J Physiol Pathophysiol Pharmacol. 2015 Mar 20;7(1):44-53. eCollection 2015. Int J Physiol Pathophysiol Pharmacol. 2015. PMID: 26069528 Free PMC article.

90

Comparison of retinal nerve fiber layer thickness in vivo and axonal transport after chronic intraocular pressure elevation in young versus older rats.

Abbott CJ, Choe TE, Burgoyne CF, Cull G, Wang L, Fortune B. Abbott CJ, et al. Among authors: cull g. PLoS One. 2014 Dec 11;9(12):e114546. doi: 10.1371/journal.pone.0114546. eCollection 2014. PLoS One. 2014. PMID: 25501362 Free PMC article.

91

The Effect of Age on Optic Nerve Axon Counts, SDOCT Scan Quality, and Peripapillary Retinal Nerve Fiber Layer Thickness Measurements in Rhesus Monkeys.

Fortune B, Reynaud J, Cull G, Burgoyne CF, Wang L. Fortune B, et al. Among authors: cull g. Transl Vis Sci Technol. 2014 May 22;3(3):2. doi: 10.1167/tvst.3.3.2. eCollection 2014 May. Transl Vis Sci Technol. 2014. PMID: 24932430 Free PMC article.

92

Optic nerve head blood flow response to reduced ocular perfusion pressure by alteration of either the blood pressure or intraocular pressure.

Wang L, Cull GA, Fortune B. Wang L, et al. Curr Eye Res. 2015 Apr;40(4):359-67. doi: 10.3109/02713683.2014.924146. Epub 2014 Jun 9. Curr Eye Res. 2015. PMID: 24911311 Free PMC article.

93

Longitudinal alterations in the dynamic autoregulation of optic nerve head blood flow revealed in experimental glaucoma.

Wang L, Cull G, Burgoyne CF, Thompson S, Fortune B. Wang L, et al. Among authors: cull g. Invest Ophthalmol Vis Sci. 2014 May 8;55(6):3509-16. doi: 10.1167/iovs.14-14020. Invest Ophthalmol Vis Sci. 2014. PMID: 24812551 Free PMC article.

94

Parametric transfer function analysis and modeling of blood flow autoregulation in the optic nerve head.

Yu J, Liang Y, Thompson S, Cull G, Wang L. Yu J, et al. Among authors: cull g. Int J Physiol Pathophysiol Pharmacol. 2014 Mar 13;6(1):13-22. eCollection 2014. Int J Physiol Pathophysiol Pharmacol. 2014. PMID: 24665355 Free PMC article.

95

Static blood flow autoregulation in the optic nerve head in normal and experimental glaucoma.

Wang L, Burgoyne CF, Cull G, Thompson S, Fortune B. Wang L, et al. Among authors: cull g. Invest Ophthalmol Vis Sci. 2014 Feb 10;55(2):873-80. doi: 10.1167/iovs.13-13716. Invest Ophthalmol Vis Sci. 2014. PMID: 24436190 Free PMC article.

96

Onset and progression of peripapillary retinal nerve fiber layer (RNFL) retardance changes occur earlier than RNFL thickness changes in experimental glaucoma.

Fortune B, Burgoyne CF, Cull G, Reynaud J, Wang L. Fortune B, et al. Among authors: cull g. Invest Ophthalmol Vis Sci. 2013 Aug 21;54(8):5653-61. doi: 10.1167/iovs.13-12219. Invest Ophthalmol Vis Sci. 2013. PMID: 23847322 Free PMC article.

97

Longitudinal hemodynamic changes within the optic nerve head in experimental glaucoma.

Cull G, Burgoyne CF, Fortune B, Wang L. Cull G, et al. Invest Ophthalmol Vis Sci. 2013 Jun 21;54(6):4271-7. doi: 10.1167/iovs.13-12013. Invest Ophthalmol Vis Sci. 2013. PMID: 23737471 Free PMC article.

98

Quantitative retinal and choroidal blood flow during light, dark adaptation and flicker light stimulation in rats using fluorescent microspheres.

Shih YY, Wang L, De La Garza BH, Li G, Cull G, Kiel JW, Duong TQ. Shih YY, et al. Among authors: cull g. Curr Eye Res. 2013 Feb;38(2):292-8. doi: 10.3109/02713683.2012.756526. Epub 2013 Jan 14. Curr Eye Res. 2013. PMID: 23317112 Free PMC article.

99

Basal blood flow and autoregulation changes in the optic nerve of rhesus monkeys with idiopathic bilateral optic atrophy.

Piper C, Fortune B, Cull G, Cioffi GA, Wang L. Piper C, et al. Among authors: cull g. Invest Ophthalmol Vis Sci. 2013 Jan 23;54(1):714-21. doi: 10.1167/iovs.12-9773. Invest Ophthalmol Vis Sci. 2013. PMID: 23287792 Free PMC article.

100

Anterior and posterior optic nerve head blood flow in nonhuman primate experimental glaucoma model measured by laser speckle imaging technique and microsphere method.

Wang L, Cull GA, Piper C, Burgoyne CF, Fortune B. Wang L, et al. Invest Ophthalmol Vis Sci. 2012 Dec 17;53(13):8303-9. doi: 10.1167/iovs.12-10911. Invest Ophthalmol Vis Sci. 2012. PMID: 23169886 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

124 results

Search Page

Filters